• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • 2026 Election
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
    • Examining Transportation
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
Advertisement
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • 2026 Election
  • America at 250
  • IN FOCUS
  • Commentary
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • Powering Progress
    • ASAE – Association Leadership
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
    • Examining Transportation
  • Newsletters
More
    Advertisement
    Home › Authors › Posts by Linda Johnson

    Linda Johnson

    Linda Johnson

    Read the latest stories and analysis from Linda Johnson.

    Pfizer aims to cut generics impact with new drugs Business

    Pfizer aims to cut generics impact with new drugs

    Linda Johnson · April 25, 2013 7:11 pm
    Bristol net plunges 45 pct. on generic competition Business

    Bristol net plunges 45 pct. on generic competition

    Linda Johnson · April 25, 2013 1:59 pm
    Earnings Preview: Amgen reports 1Q results Tuesday Business

    Earnings Preview: Amgen reports 1Q results Tuesday

    Linda Johnson · April 19, 2013 10:26 am
    Earnings Preview: J&J 1Q to focus on newest drugs Business

    Earnings Preview: J&J 1Q to focus on newest drugs

    Linda Johnson · April 12, 2013 4:23 pm
    Advertisement
    Merck: FDA reviewing pill form of antifungal drug Business

    Merck: FDA reviewing pill form of antifungal drug

    Linda Johnson · April 10, 2013 6:19 pm
    Pfizer breast cancer drug gets breakthrough label Business

    Pfizer breast cancer drug gets breakthrough label

    Linda Johnson · April 10, 2013 5:17 pm
    Bradway salary jumps in first year as Amgen’s CEO Business

    Bradway salary jumps in first year as Amgen’s CEO

    Linda Johnson · April 9, 2013 1:20 am
    Merck: FDA reviewing tablet to eliminate allergy Business

    Merck: FDA reviewing tablet to eliminate allergy

    Linda Johnson · March 27, 2013 10:40 pm
    Advertisement
    Novel Amgen virus-vaccine shrinks melanoma tumors Business

    Novel Amgen virus-vaccine shrinks melanoma tumors

    Linda Johnson · March 20, 2013 8:34 pm
    Merck: FDA needs more time to review surgery drug Business

    Merck: FDA needs more time to review surgery drug

    Linda Johnson · March 15, 2013 4:09 pm
    J&J lowers exec bonuses, citing ‘disappointments’ Business

    J&J lowers exec bonuses, citing ‘disappointments’

    Linda Johnson · March 13, 2013 10:37 pm
    Drugmakers, Interpol ramp up fight against fakes Business

    Drugmakers, Interpol ramp up fight against fakes

    Linda Johnson · March 12, 2013 5:01 am
    Advertisement
    • ‹Previous page
    • 1
    • …
    • 3
    • 4
    • 5
    • 6
    • 7
    • …
    • 10
    • ›Next page
    Page 5 of 10
    Advertisement
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism and Unity
    • Faith, Freedom, and Self-Reliance
    • Courage, Strength, and Optimism
    • Equality, Not Elitism
    • Community and Family
    • Fairness and Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter
    • © Copyright 2026. Washington Examiner. All Rights Reserved.